Prophylactic use of interferon alfa after bone marrow transplantation for patients with chronic myelogenous leukemia at high risk of relapse: a pilot study. The Chronic Leukemia Working Party of the EBMT.
作者信息
Niederwieser D, Arcese W, Bandini G, Schwaighofer H, Thaler J, Bosi A, Di Bartolomeo P, Alessandrino E P, Urban C, Gratwohl A
机构信息
Department of Internal Medicine, University Hospital, Innsbruck, Austria.
出版信息
Semin Hematol. 1993 Jul;30(3 Suppl 3):40-3.
PMID:8235706
Abstract
摘要
相似文献
1
2
3
Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.采用大剂量白消安和环磷酰胺（BU-CY）作为预处理方案进行无关供者异基因骨髓移植。
Bone Marrow Transplant. 1996 May;17(5):685-9.
4
Adoptive immunotherapy in human and canine chimeras--the role of interferon alfa. EBMT Chronic Leukemia Working Party.人类和犬类嵌合体中的过继性免疫疗法——α干扰素的作用。欧洲血液与骨髓移植协会慢性白血病工作组。
Semin Hematol. 1993 Jul;30(3 Suppl 3):37-9.
5
Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.慢性期慢性粒细胞白血病异基因骨髓移植后的长期结果：欧洲血液和骨髓移植组慢性白血病工作组的报告
Bone Marrow Transplant. 1997 Oct;20(7):553-60. doi: 10.1038/sj.bmt.1700933.
6
[Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation].
Beitr Infusionsther Transfusionsmed. 1994;32:276-80.
7
Haploidentical family member transplants for patients with chronic myeloid leukaemia: a report of the Chronic Leukaemia Working Party of off European Group for Blood and Marrow Transplantation (EBMT).慢性髓性白血病患者的单倍体相合家庭成员移植：欧洲血液与骨髓移植组（EBMT）慢性白血病工作组报告
Bone Marrow Transplant. 1997 Jun;19(12):1197-203. doi: 10.1038/sj.bmt.1700792.
8
9
引用本文的文献
1
Biotherapy of chronic myelogenous leukemia.
Ann Hematol. 1995 Mar;70(3):113-20. doi: 10.1007/BF01682030.
Zotero 插件